Cartilage diseases.
暂无分享,去创建一个
[1] F. Berenbaum,et al. Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis , 2017, Arthritis & rheumatology.
[2] J. Carey,et al. Treatment algorithm for osteochondritis dissecans of the knee. , 2014, Clinics in sports medicine.
[3] Thelma Skare,et al. Jaccoud arthropathy in systemic lupus erythematosus: clinical and serological findings. , 2012, Revista da Associacao Medica Brasileira.
[4] M. Hochberg,et al. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. , 2017, Osteoarthritis and cartilage.
[5] B. Alman,et al. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets , 2010, Nature Reviews Cancer.
[6] R. Moots,et al. The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. , 2012, Autoimmunity reviews.
[7] H. Gelderblom,et al. The clinical approach towards chondrosarcoma. , 2008, The oncologist.
[8] Gorjan Alagic,et al. #p , 2019, Quantum information & computation.
[9] P. Guerne,et al. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. , 2007, Arthritis and rheumatism.
[10] F. C. Linn,et al. Lubrication of animal joints. I. The arthrotripsometer. , 1967, The Journal of bone and joint surgery. American volume.
[11] G. Mccarthy,et al. Treatment and management of pseudogout: insights for the clinician , 2012, Therapeutic advances in musculoskeletal disease.
[12] P. Beighton,et al. Spondyloepiphyseal dysplasia, mild autosomal dominant type is not due to primary defects of type II collagen. , 1990, American journal of medical genetics.
[13] B Schoeberl,et al. Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis. , 2014, Osteoarthritis and cartilage.
[14] A. Franchi. Epidemiology and classification of bone tumors. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[15] M. Briggs,et al. The aggrecanopathies; an evolving phenotypic spectrum of human genetic skeletal diseases , 2016, Orphanet Journal of Rare Diseases.
[16] P. Hammond,et al. Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. , 2015, Osteoarthritis and cartilage.
[17] R. Terkeltaub,et al. TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation1 , 2005, The Journal of Immunology.
[18] M. Lotz. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options , 2010 .
[19] Garry E Gold,et al. Diagnosis of osteoarthritis: imaging. , 2012, Bone.
[20] R. Fässler,et al. Sensing the mechano-chemical properties of the extracellular matrix. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[21] X. Bai,et al. Strontium ranelate, a promising disease modifying osteoarthritis drug , 2017, Expert opinion on investigational drugs.
[22] G. Vawter,et al. Nonexpression of cartilage type II collagen in a case of Langer-Saldino achondrogenesis. , 1986, American journal of human genetics.
[23] D. Mccarty. The Significance of Calcium Phosphate Crystals in the Synovial Fluid of Arthritic Patients: The Pseudogout Syndrome: I. Clinical Aspects , 1962 .
[24] R. Russell,et al. Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals. , 1983, Annals of the rheumatic diseases.
[25] R. Kosaki,et al. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type , 2004, Journal of Medical Genetics.
[26] B. Rothschild,et al. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. , 1997, Comprehensive therapy.
[27] E. Vignon,et al. When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program , 2016, Arthritis & rheumatology.
[28] M. Kocher,et al. Osteochondritis Dissecans of the Knee , 2015, JBJS reviews.
[29] PTHrP , 2019, Springer Reference Medizin.
[30] J CHARNLEY,et al. The Lubrication of Animal Joints in Relation to Surgical Reconstruction by Arthroplasty * , 1960, Annals of the rheumatic diseases.
[31] S. Mundlos,et al. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development‐transcription factors and signaling pathways 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] F. Berenbaum,et al. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis , 2012, Osteoporosis International.
[33] J. Dudhia. Aggrecan, aging and assembly in articular cartilage , 2005, Cellular and Molecular Life Sciences CMLS.
[34] M. Peterson,et al. Burden of childhood-onset arthritis , 2010, Pediatric rheumatology online journal.
[35] G. Schulze-Tanzil,et al. Osteoarthritis and the Complement Cascade , 2018, Clinical medicine insights. Arthritis and musculoskeletal disorders.
[36] Christine Ortiz,et al. Time-dependent nanomechanics of cartilage. , 2011, Biophysical journal.
[37] Kathryn L Bauer,et al. Management of Osteochondritis Dissecans Lesions of the Knee, Elbow and Ankle. , 2017, Clinics in sports medicine.
[38] H. Muir,et al. Proteoglycans as organizers of the intercellular matrix. , 1983, Biochemical Society transactions.
[39] B. Mandell,et al. Update on Crystal-Induced Arthritides. , 2017, Clinics in geriatric medicine.
[40] F. Beier,et al. Targeting oxidative stress to reduce osteoarthritis , 2016, Arthritis Research & Therapy.
[41] H. Levine,et al. Relapsing polychondritis — REPORT OF TEN CASES , 1979, The Laryngoscope.
[42] D. Heinegård,et al. A Novel Cartilage Protein (CILP) Present in the Mid-zone of Human Articular Cartilage Increases with Age* , 1998, The Journal of Biological Chemistry.
[43] C. Alves,et al. Metaphyseal Condrodysplasia, Schmid-type, a Differential Diagnosis with Rickets , 2010, Journal of pediatric endocrinology & metabolism : JPEM.
[44] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[45] Sheila Unger,et al. Nosology and classification of genetic skeletal disorders: 2015 revision , 2015, American journal of medical genetics. Part A.
[46] P. Guerne,et al. Treating difficult crystal pyrophosphate dihydrate deposition disease , 2008, Current rheumatology reports.
[47] W M O'Fallon,et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. , 1986, Annals of internal medicine.
[48] D. Green,et al. Classification and assessment of juvenile osteochondritis dissecans knee lesions , 2016, Current opinion in pediatrics.
[49] A. Papavassiliou,et al. ROS/oxidative stress signaling in osteoarthritis. , 2016, Biochimica et biophysica acta.
[50] U. Müller-Ladner,et al. Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[51] F. Eckstein,et al. Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging , 2015, Arthritis & rheumatology.
[52] M. Heymann,et al. Biology of Bone Sarcomas and New Therapeutic Developments , 2017, Calcified Tissue International.
[53] P. Beighton,et al. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. , 2005, American journal of human genetics.
[54] M. Karsdal,et al. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future. , 2016, Osteoarthritis and cartilage.
[55] J. Polousky,et al. Salvage techniques in osteochondritis dissecans. , 2014, Clinics in sports medicine.
[56] A. Grodzinsky,et al. Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra‐articular injected avidin in rat knee joints , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[57] V. Kraus,et al. The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes On the Offensive , 2015, The Journal of Rheumatology.
[58] P. Mishra,et al. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. , 2017, Osteoarthritis and cartilage.
[59] A. Haj-Mirzaian,et al. Bisphosphonates intake and its association with changes of periarticular bone area and three-dimensional shape: data from the Osteoarthritis Initiative (OAI). , 2018, Osteoarthritis and cartilage.
[60] G. Dubyak,et al. The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes , 2013, Arthritis Research & Therapy.
[61] H. Haubeck. Aggrecan , 2019, Springer Reference Medizin.
[62] N. Lane,et al. Osteoarthritis in 2016: Anti-NGF treatments for pain — two steps forward, one step back? , 2017, Nature Reviews Rheumatology.
[63] M. Klein-Gitelman,et al. An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus , 2016, Rheumatology and Therapy.
[64] Marie-Christine Chaboissier,et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.
[65] M. Walter,et al. Genetic study of SOX9 in a case of campomelic dysplasia. , 2001, American journal of medical genetics.
[66] M. Doherty,et al. Gout. Epidemiology of gout , 2010, Arthritis Research & Therapy.
[67] Arnold Munnich,et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.
[68] B. Daly,et al. Overview of epidemiology , 2013 .
[69] Yang Wang,et al. Intra‐articular dexamethasone to inhibit the development of post‐traumatic osteoarthritis , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[70] J. Polousky,et al. A Review of Knowledge in Osteochondritis Dissecans: 123 Years of Minimal Evolution from König to the ROCK Study Group , 2013, Clinical orthopaedics and related research.
[71] Changqing Zhang,et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes , 2013, Arthritis Research & Therapy.
[72] Muhammad Asim Khan,et al. Update on Spondyloarthropathies , 2002, Annals of Internal Medicine.
[73] A. Grodzinsky,et al. Quantitative proteomics analysis of cartilage response to mechanical injury and cytokine treatment. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[74] D. Danks,et al. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. , 1979, Journal of medical genetics.
[75] T. Hardingham,et al. Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] H. A. T. Fairbank. Osteo‐chondritis dissecans , 1933 .
[77] A. Boskey,et al. Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. , 1992, Arthritis and rheumatism.
[78] D. Trentham,et al. Relapsing Polychondritis , 1998, Annals of Internal Medicine.
[79] A. Mikos,et al. Strategies for controlled delivery of biologics for cartilage repair. , 2015, Advanced drug delivery reviews.
[80] Peter G. Schultz,et al. A Stem Cell–Based Approach to Cartilage Repair , 2012, Science.
[81] Peter D Kent,et al. Relapsing polychondritis. , 2004, Current opinion in rheumatology.
[82] K. Muir,et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte , 2003, Annals of the rheumatic diseases.
[83] M. Karsdal,et al. Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo , 2017, Journal of Translational Medicine.
[84] O. Akgul,et al. Classification criteria for spondyloarthropathies. , 2011, World journal of orthopedics.
[85] C. Pearson,et al. RELAPSING POLYCHONDRITIS: Prospective Study of 23 Patients and A Review of the Literature , 1976, Medicine.
[86] N Maffulli,et al. Physeal injuries in children’s and youth sports: reasons for concern? , 2006, British Journal of Sports Medicine.
[87] B Lindén,et al. The incidence of osteochondritis dissecans in the condyles of the femur. , 1976, Acta orthopaedica Scandinavica.
[88] B. Zabel,et al. Survival to adulthood and dominant inheritance of platyspondylic skeletal dysplasia, Torrance-Luton type , 2003, Pediatric Radiology.
[89] H. Schumacher,et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. , 2003, Osteoarthritis and cartilage.
[90] F. C. Linn. Lubrication of Animal Joints , 1969 .
[91] M. Bawendi,et al. Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. , 2014, Biomaterials.
[92] D. Heinegård,et al. Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. , 1986, The Journal of biological chemistry.
[93] Hyon K. Choi,et al. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.
[94] B. Crombrugghe,et al. Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .
[95] A. Maroudas,et al. Transport of solutes through cartilage: permeability to large molecules. , 1976, Journal of anatomy.
[96] D. Strickland,et al. MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1 , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[97] Ali Guermazi,et al. Advances in imaging of osteoarthritis and cartilage. , 2011, Radiology.
[98] A. Rosenthal,et al. Calcium Pyrophosphate Deposition Disease. , 2016, The New England journal of medicine.
[99] D. Hunter,et al. Monoclonal antibodies for the treatment of osteoarthritis , 2016, Expert opinion on biological therapy.
[100] D. Caborn,et al. Articular Cartilage Changes Seen With Magnetic Resonance Imaging-Detected Bone Bruises Associated With Acute Anterior Cruciate Ligament Rupture , 1998, The American journal of sports medicine.
[101] A. Cleton-Jansen,et al. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. , 2005, The Lancet. Oncology.
[102] A. Grodzinsky,et al. Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis. , 2017, European cells & materials.
[103] J. Elisseeff,et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment , 2017, Nature Medicine.
[104] J. Sokolove,et al. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations , 2013, Therapeutic advances in musculoskeletal disease.
[105] C. Jorcyk,et al. Endoplasmic Reticulum Stress and Unfolded Protein Response in Cartilage Pathophysiology; Contributing Factors to Apoptosis and Osteoarthritis , 2017, International journal of molecular sciences.
[106] S. Patterson,et al. Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.
[107] J. Reveille. Epidemiology of Spondyloarthritis in North America , 2011, The American journal of the medical sciences.
[108] J. Vaněk. Spondyloepiphyseal dysplasia. , 1983, Journal of medical genetics.
[109] A. Fabre,et al. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies , 2016, Human mutation.
[110] J. Ogden. Skeletal Growth Mechanism Injury Patterns , 1982, Journal of pediatric orthopedics.
[111] B. Olsen,et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia , 1993, Nature Genetics.
[112] S. Mundlos,et al. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development‐matrix components and their homeostasis , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[113] J. J. Butler,et al. The high prevalence of pathologic calcium crystals in pre-operative knees. , 2002, The Journal of rheumatology.
[114] S. Nelson,et al. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. , 2009, American journal of human genetics.
[115] D. Mccarty,et al. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. , 1962, Annals of internal medicine.
[116] A Ratcliffe,et al. Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. , 1992, Biomaterials.
[117] D. Gladman,et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.
[118] Daniel Cuestas,et al. Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review , 2017, International journal of dermatology.
[119] G. Lyritis,et al. Strontium Ranelate , 2006, Annals of the New York Academy of Sciences.
[120] Tsuyoshi Murata,et al. {m , 1934, ACML.
[121] P. Leder,et al. Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.
[122] David T Felson,et al. Updated Estimates Suggest a Much Higher Prevalence of Arthritis in United States Adults Than Previous Ones , 2018, Arthritis & rheumatology.
[123] J. Hood,et al. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. , 2018, Osteoarthritis and cartilage.
[124] C. Hughes. Kinesiology: The Mechanics and Pathomechanics of Human Movement , 2004 .
[125] M. Kocher,et al. Drilling techniques for osteochondritis dissecans. , 2014, Clinics in sports medicine.
[126] S. Majumdar,et al. Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study , 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[127] B. Olsen,et al. Collagen IX. , 1997, The international journal of biochemistry & cell biology.
[128] James A. Martin,et al. Post‐traumatic osteoarthritis: Improved understanding and opportunities for early intervention , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[129] M. Nevitt,et al. Biomarkers for osteoarthritis: current position and steps towards further validation. , 2014, Best practice & research. Clinical rheumatology.
[130] W. Knudson,et al. CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[131] F. Guilak,et al. The structure and function of the pericellular matrix of articular cartilage. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[132] Ryan P. Russell,et al. The enthesis: a review of the tendon-to-bone insertion. , 2014, Muscles, ligaments and tendons journal.
[133] J. Ralphs,et al. Fibrocartilage in tendons and ligaments — an adaptation to compressive load , 1998, Journal of anatomy.
[134] P. Maroteaux,et al. Homozygous achondroplasia: morphologic and biochemical study of cartilage. , 1990, American journal of medical genetics.
[135] Tamás Vicsek,et al. A nationwide study of the epidemiology of relapsing polychondritis , 2016, Clinical epidemiology.
[136] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[137] Takako Sasaki,et al. A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. , 2010, American journal of human genetics.
[138] A. Poole. Osteoarthritis as a Whole Joint Disease , 2012, HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
[139] D. Eyre,et al. Articular cartilage collagen: an irreplaceable framework? , 2006, European cells & materials.
[140] J P Green. Osteochondritis dissecans of the knee. , 1966, The Journal of bone and joint surgery. British volume.
[141] J. Foidart,et al. Antibodies to type II collagen in relapsing polychondritis. , 1978, The New England journal of medicine.
[142] Steven F. Isenberg. Relapsing Polychondritis , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[143] R. Boot-Handford,et al. The unfolded protein response and its relevance to connective tissue diseases , 2009, Cell and Tissue Research.
[144] C. Helmick,et al. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. , 2007, Arthritis and rheumatism.
[145] P. Roughley. Articular cartilage and changes in arthritis: Noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage , 2001, Arthritis research.
[146] F. Berenbaum,et al. Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.
[147] M. Santiago,et al. Jaccoud Arthropathy in Systemic Lupus Erythematosus: Analysis of Clinical Characteristics and Review of the Literature , 2008, Medicine.
[148] L. Miller,et al. Open Access Journal of Sports Medicine Dovepress Post-traumatic Knee Osteoarthritis in the Young Patient: Therapeutic Dilemmas and Emerging Technologies , 2022 .
[149] S. Shiokawa,et al. Clonal analysis of B cells in the osteoarthritis synovium , 2001, Annals of the rheumatic diseases.
[150] W. Kannel,et al. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. , 1989, The Journal of rheumatology.
[151] F. Konig. The Classic: On Loose Bodies in the Joint , 2013 .
[152] Kristina Buac,et al. Pseudogout-Associated Inflammatory Calcium Pyrophosphate Dihydrate Microcrystals Induce Formation of Neutrophil Extracellular Traps , 2013, The Journal of Immunology.
[153] R. Iozzo,et al. A current view of perlecan in physiology and pathology: A mosaic of functions. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[154] P. Aichroth. OSTEOCHONDRITIS DISSECANS OF THE KNEE: A Clinical Survey , 1971 .
[155] J. Healey,et al. Cartilage Tumors: Evaluation and Treatment , 2000, The Journal of the American Academy of Orthopaedic Surgeons.
[156] D. Veale. Psoriatic arthritis: recent progress in pathophysiology and drug development , 2013, Arthritis Research & Therapy.
[157] F. Breedveld,et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. , 1993, Arthritis and rheumatism.
[158] J. Jurvelin,et al. A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis. , 2016, Clinical and experimental rheumatology.
[159] T. Aigner,et al. Immunolocalization of matrix proteins in different human cartilage subtypes. , 2006, Histology and histopathology.
[160] R. Terkeltaub,et al. Emerging regulators of the inflammatory process in osteoarthritis , 2015, Nature Reviews Rheumatology.
[161] First in Human , 2020, Definitions.
[162] G. Shaw,et al. The population‐based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US , 2008, American journal of medical genetics. Part A.
[163] W. Robert Harris,et al. Injuries Involving the Epiphyseal Plate , 1963 .
[164] P. Patwari,et al. Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. , 2003, Journal of structural biology.
[165] R. Schenck,et al. Current Concept Review - Osteochondritis Dissecans* , 1996 .
[166] A. Rosenthal,et al. Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK , 2011, Connective tissue research.
[167] M. Dougados,et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.
[168] A. Gibofsky,et al. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. , 2012, The American journal of managed care.
[169] L. Dodd,et al. The Clinical Management of Chondrosarcoma , 2009, Current treatment options in oncology.
[170] E. Maverakis,et al. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. , 2017, Journal of autoimmunity.
[171] G. Mortier,et al. Dominant negative mutations in the C‐propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies , 2005, American journal of medical genetics. Part A.
[172] Martin Michaelis,et al. Osteoarthritis — an untreatable disease? , 2005, Nature Reviews Drug Discovery.
[173] D. Heinegård,et al. Matrix proteins bound to associatively prepared proteoglycans from bovine cartilage. , 1979, The Biochemical journal.
[174] Thomas D Brown,et al. Posttraumatic Osteoarthritis: A First Estimate of Incidence, Prevalence, and Burden of Disease , 2006, Journal of orthopaedic trauma.
[175] Alberto Martini,et al. Juvenile Idiopathic Arthritis , 2000, The Lancet.
[176] L. Setton,et al. Progress in intra-articular therapy , 2014, Nature Reviews Rheumatology.
[177] L. Wenger,et al. Induction of Matrix Metalloproteinase-8 in Human Fibroblasts by Basic Calcium Phosphate and Calcium Pyrophosphate Dihydrate Crystals: Effect of Phosphocitrate , 2001, Connective tissue research.
[178] Jeffrey B. Driban,et al. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial , 2017, JAMA.
[179] A. Grodzinsky,et al. Age-related nanostructural and nanomechanical changes of individual human cartilage aggrecan monomers and their glycosaminoglycan side chains. , 2012, Journal of structural biology.
[180] Duncan Dowson,et al. The Frictional Behavior of Human Synovial Joints—Part I: Natural Joints , 1975 .
[181] I. Shapiro,et al. Syndecan-4 in intervertebral disc and cartilage: Saint or synner? , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[182] C. Shu,et al. The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation. , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[183] J. Yates,et al. Clinical and molecular genetics of Stickler syndrome , 1999, Journal of medical genetics.
[184] A. Rosenthal,et al. Metabolism of extracellular pyrophosphate. , 2003, Current opinion in rheumatology.
[185] W. B. van den Berg,et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. , 2010, Arthritis and rheumatism.
[186] Gregory Choy. An update on the treatment options for gout and calcium pyrophosphate deposition , 2005, Expert opinion on pharmacotherapy.
[187] D Dowson,et al. Some new evidence on human joint lubrication. , 1975, Annals of the rheumatic diseases.
[188] E. Schipani,et al. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. , 2003, Birth defects research. Part C, Embryo today : reviews.
[189] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[190] König,et al. Ueber freie Körper in den Gelenken , 1888, Deutsche Zeitschrift für Chirurgie.
[191] S. Mundlos,et al. An alpha 1(II) Gly913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. , 1996, American journal of medical genetics.
[192] M. Englund,et al. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. , 2012, Osteoarthritis and cartilage.
[193] L. Soslowsky,et al. Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[194] Y. Tegner,et al. Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature. , 2008, Osteoarthritis and cartilage.
[195] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[196] D. Heinegård,et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. , 1992, The Journal of biological chemistry.
[197] M. Díaz-Almirón,et al. Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria—A Follow-Up , 2016, Journal of oncology.
[198] R. Sanmartí,et al. Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. , 1993, Annals of the rheumatic diseases.
[199] Matthias Schneider,et al. Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. , 2003, Arthritis and rheumatism.
[200] F. Salvo,et al. Does paracetamol still have a future in osteoarthritis? , 2016, The Lancet.
[201] N. Bottini,et al. Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. , 2014, ACS nano.
[202] Alan J. Grodzinsky,et al. Cartilage-targeting drug delivery: can electrostatic interactions help? , 2017, Nature Reviews Rheumatology.
[203] Nicole Gerwin,et al. Intraarticular drug delivery in osteoarthritis. , 2006, Advanced drug delivery reviews.
[204] K. Shea,et al. The Demographics and Epidemiology of Osteochondritis Dissecans of the Knee in Children and Adolescents , 2014, The American journal of sports medicine.
[205] G. Herrero-Beaumont,et al. TLR4 signalling in osteoarthritis—finding targets for candidate DMOADs , 2015, Nature Reviews Rheumatology.
[206] J. Weiss,et al. Osteochondritis dissecans of the knee: pathoanatomy, epidemiology, and diagnosis. , 2014, Clinics in sports medicine.
[207] D. Eyre. Articular cartilage and changes in Arthritis: Collagen of articular cartilage , 2001, Arthritis research.
[208] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[209] E. Schipani,et al. Molecular mechanisms of endochondral bone development. , 2005, Biochemical and biophysical research communications.
[210] Eric W Edmonds,et al. Osteochondritis Dissecans: Editorial Comment , 2013, Clinical orthopaedics and related research.
[211] J O S E P,et al. Biomechanics of cartilage , 2013 .
[212] D. Fox,et al. Advances in the medical treatment of rheumatoid arthritis. , 2011, Hand clinics.
[213] D. Church,et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.
[214] P. Guerne,et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial , 2014, Arthritis Research & Therapy.
[215] C. Platsoucas,et al. The role of T cells in the pathogenesis of osteoarthritis. , 2007, Arthritis and rheumatism.
[216] V. Wilairatana,et al. Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis. , 2007, Osteoarthritis and cartilage.
[217] S. Carr,et al. The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[218] R. Stockwell. The cell density of human articular and costal cartilage. , 1967, Journal of anatomy.
[219] Gregory D Jay,et al. The biology of lubricin: near frictionless joint motion. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[220] P. Roughley,et al. The structure and function of cartilage proteoglycans. , 2006, European cells & materials.
[221] E. Hohenester,et al. Structural and functional analysis of two small leucine-rich repeat proteoglycans, fibromodulin and chondroadherin , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[222] Simon W. Jones,et al. Developing anti-inflammatory therapeutics for patients with osteoarthritis , 2016, Rheumatology.
[223] Hyon K. Choi,et al. Psoriatic arthritis epidemiology , 2007, Current rheumatology reports.
[224] J. Kay,et al. Evolution of treatment for rheumatoid arthritis. , 2012, Rheumatology.
[225] H. Kronenberg,et al. Developmental regulation of the growth plate , 2003, Nature.
[226] A. Winterpacht,et al. The type II collagenopathies: A spectrum of chondrodysplasias , 1994, European Journal of Pediatrics.
[227] Aman Sharma,et al. Relapsing polychondritis: a review , 2013, Clinical Rheumatology.
[228] F. Eckstein,et al. Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2014, Arthritis & rheumatology.
[229] S. Mundlos,et al. A COL2A1 Mutation in Achondrogenesis Type II Results in the Replacement of Type II Collagen by Type I and III Collagens in Cartilage (*) , 1995, The Journal of Biological Chemistry.
[230] P. Marie,et al. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.
[231] K. Kalunian,et al. New developments in osteoarthritis. , 2005, Clinics in geriatric medicine.